Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “glp1 Agonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01455441
What this trial is testing

The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Tina Vilsboll 40
Post-approval studies (Phase 4)Looking for participantsNCT07127354
What this trial is testing

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Who this might be right for
GLP - 1Bowel Preparation for Colonoscopy
The Cleveland Clinic 132
Early research (Phase 1)Not Yet RecruitingNCT07140055
What this trial is testing

A Research Study to Evaluate BLX-7006 in Healthy Adults

Who this might be right for
Normal Healthy VolunteerSafety After Oral Intake
Biolexis Therapeutics 76
Early research (Phase 1)Looking for participantsNCT07693426
What this trial is testing

Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

Who this might be right for
Adolescence Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511543
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

Who this might be right for
Ischemic Stroke
Population Health Research Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT06903923
What this trial is testing

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Who this might be right for
Obesity in ChildrenBone StrengthGLP - 1+3 more
University of Virginia 120
Post-approval studies (Phase 4)Study completedNCT02049034
What this trial is testing

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Surrey 8
Post-approval studies (Phase 4)Not Yet RecruitingNCT07462663
What this trial is testing

SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Cancer Stage IAtypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I+6 more
Hospital Universitari de Bellvitge 80
Early research (Phase 1)Not Yet RecruitingNCT07550621
What this trial is testing

Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

Who this might be right for
Healthy Volunteers (HV)
MindRank AI Ltd 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Not applicableLooking for participantsNCT07789223
What this trial is testing

Weight and Metabolic Management Study

Who this might be right for
OverweightObesityWeight Maintenance
Elenzia 200
Not applicableLooking for participantsNCT07732738
What this trial is testing

Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

Who this might be right for
Obesity
China-Japan Friendship Hospital 400
Not applicableNot Yet RecruitingNCT07175805
What this trial is testing

Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy

Who this might be right for
Lower Urinary Tract SymptomsStress Urinary IncontinenceUrge Urinary Incontinence+6 more
Hartford HealthCare 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Not applicableNot Yet RecruitingNCT07770906
What this trial is testing

Effect of GLP-1 Receptor Agonists on Periodontal Health and Response to Nonsurgical Periodontal Therapy

Who this might be right for
Periodontal DiseaseObesity & Overweight
Cukurova University 40
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Post-approval studies (Phase 4)Study completedNCT03292315
What this trial is testing

Once Weekly GLP-1 in Persons With Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesInsulin ResistancePre Diabetes+1 more
James J. Peters Veterans Affairs Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT04199728
What this trial is testing

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Who this might be right for
Opiate Substitution TreatmentOpioid-Related Disorders
Milton S. Hershey Medical Center 27
Large-scale testing (Phase 3)Study completedNCT00866658
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 311
Next Page